Inventor

HUBLER FRANCIS

SE19 patents

⚠️ This page may combine multiple inventors who share the name “HUBLER FRANCIS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HUBLER FRANCIS

ACTELION PHARMACEUTICALS LTD

Pyrimidine derivatives and their use as P2Y12 receptor antagonists

Heterocyclic amide derivatives as P2X7 receptor antagonists

Indole carboxamide derivatives as P2X7 receptor antagonist

Indole carboxamide derivatives as P2X7 receptor antagonists

Heterocyclic amide derivatives as P2X7 receptor antagonists

HILPERT KURT

Heterocyclic amide derivatives as P2X7 receptor antagonists

Bridged six-membered ring compounds

Heterocyclic amide derivatives as P2X7 receptor antagonists

Tetrahydronaphthalene compounds

Bridged tetrahydronaphthalene derivatives

CAROFF EVA

Phosphonic acid derivates and their use as P2Y12 receptor antagonists

6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines

Substituted 2-phenyl-pyridine derivatives

Thiazole derivatives and their use as P2Y12 receptor antagonists

IDORSIA PHARMACEUTICALS LTD

C5A receptor modulators

C5a receptor modulators

Substituted tetrahydropyrazolo[3,4-d]pyrimidines and tetrahydropyrazolo[4,3-d]pyrimidines as C5A receptor modulators

ABELE STEFAN

Salts of isobutyric acid (1 R*, 2R*, 4R*)-2-(2-{[3-(4,7-dimethoxy-1 H-benzoimidazol-2-yl)-methyl-amino}-ethyl)-5-phenyl-bicyclo[2.2.2]oct-5-en-2-yl ester

DEBIOPHARM SA

Cyclic undecapeptide pro-drugs and uses thereof

Salts of isobutyric acid (1 R, 2R, 4R*)-2-(2-{[3-(4,7-dimethoxy-1 H-benzoimidazol-2-yl)-methyl-amino}-ethyl)-5-phenyl-bicyclo[2.2.2]oct-5-en-2-yl ester